Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03851861 · ClinicalTrials.gov registry record · NA
Dietary Intervention and Gastrointestinal Function in Patients With Parkinson's Disease
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03851861: Completed NA study, sponsored by University of Florida.
NCT03851861 is a NA study that has completed, run by University of Florida. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03851861, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
In this prospective, intervention study, participants with diagnosed Parkinson's disease will be instructed to follow a Mediterranean diet for five weeks. Gut permeability will be assessed using food-grade sugar molecules. Participants will provide urine and stool samples to assess gut permeability and microbial communities.
Primary Outcome
The primary outcome is the change in gastroduodenal permeability induced by the Mediterranean diet. Gastroduodenal permeability will be assessed by measuring sucrose concentration in the 0 to 5-hour urine collection (end of intervention minus baseline)
Interventions
- OTHER Mediterranean Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2021-05-03 |
| Phase | NA |
What the finished NCT03851861 record still lists
NCT03851861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Mediterranean Diet is the first listed.
NCT03851861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03851861 about?
NCT03851861 is a clinical study titled "Dietary Intervention and Gastrointestinal Function in Patients With Parkinson's Disease". In this prospective, intervention study, participants with diagnosed Parkinson's disease will be instructed to follow a Mediterranean diet for five weeks. Gut permeability will be assessed using food-grade sugar molecules. Participants will provide urine and stool samples to assess gut permeability ...
What is the current status of trial NCT03851861?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-04-15. Estimated completion is 2021-05-03.
What interventions are being tested in trial NCT03851861?
The interventions under investigation include: Mediterranean Diet (OTHER).
Who is sponsoring clinical trial NCT03851861?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03851861's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI